2015 - 2019. Global HER2-Negative Breast Cancer Market Size and Share, Growth, Market Price, Analysis, Forecast and Overview

Text-only Preview

Hexa Reports
Market Research Reports and Insightful Company Profiles
Global HER2-Negative Breast Cancer Market Size
and Share, Growth, Market Price, Analysis, Forecast
and Overview 2015 - 2019
HER2-negative breast cancer is a subtype of breast cancer and is the condition when the HER2 is
expressed less in the tumor. According to the American Society of Clinical Oncology, most of the
patients with breast cancer are known to have HER2-negative breast cancer. HER2-negative breast
cancer patients can also be hormone receptor positive (HR+). The HER2 protein is found on the outer
surface of the breast cells, and the hormone receptors are found inside breast cells. The cancers that
have detectable hormone receptors are known as HR+ breast cancer, and those with HER2-negative
have a low level of HER2 gene or the HER2 protein. HER2-negative breast cancer can also be HR+ and
then the most preferred therapy is hormone therapy. These patients can be treated with chemotherapy
or targeted therapy to improve their condition.
Browse Detail Report With TOC @ http://www.hexareports.com/report/global-her2-negative-breast-
cancer-market/details
Covered in this report
This report covers the present scenario and the growth prospects of the global HER2-negative breast
cancer market for the period 2015-2019. To calculate the market size, the report considers revenue
generated from the sales of various off-label and branded drugs and the expected launch of drug
candidates intended to be used in the treatment of HER2-negative breast cancer.
Table Of Content
PART 01: Executive summary
Highlights
PART 02: Scope of the report
Hexa Reports
Market Research Reports and Insightful Company Profiles
Market overview
Top vendor offerings
PART 03: Market research methodology
Research methodology
Economic indicators
Request A Sample copy of This Report @ http://www.hexareports.com/sample/50091
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by type of drug molecule
Biologics
Small molecules
PART 07: Market segmentation by route of administration
Oral
Parenteral
PART 08: Geographical segmentation
Market segmentation by geography 2014-2019
HER2-negative breast cancer market in Americas 2014-2019
HER2-negative breast cancer market in EMEA 2014-2019
HER2-negative breast cancer market in APAC 2014-2019
PART 09: Pipeline portfolio
Key information about late-stage pipeline candidates
PART 10: Market drivers
PART 11: Impact of drivers
PART 12: Market challenges
PART 13: Impact of drivers and challenges
PART 14: Market trends
PART 15: Vendor landscape
Competitive scenario
Key news
Browse Full Report @ http://www.hexareports.com/report/global-her2-negative-breast-cancer-
market/details
Hexa Reports
Market Research Reports and Insightful Company Profiles
About Us:
Hexa Reports is a market research and consulting organization, offering industry reports, custom
research and consulting services to a host of key industries across the globe. We offer comprehensive
business intelligence in the form of industry reports which help our clients obtain clarity about their
business environment and enable them to undertake strategic growth initiatives.
Contact Information:
Ryan Shaw
Felton Office Plaza,
6265 Highway 9,
Felton, California, 95018,
United States
Phone Number
1-800-489-3075
Email Us: [email protected]
Our Website: http://www.hexareports.com/
Our Blog: http://hexareports.blogspot.in/